NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Rigel Pharmaceuticals, Inc. announced that fostamatinib, its oral spleen tyrosine kinase (SYK) inhibitor, met the primary endpoint in the first of two double-blind studies in the FIT Phase 3 clinical program for the treatment of adult chronic/persistent immune thrombocytopenia (ITP).  The study (n=76) showed that 18% of patients receiving fostamatinib…

news

Oncolys BioPharma Inc Says it submitted clinical trial plan (protocol) to the United States Food and Drug Administration for phase II clinical trial of oncolytic virus OBP-301 (Telomelysin) in U.S. Says unresectable or metastatic malignant melanoma is the target of the clinical trial.   Source : reuters.com

news

Drug firm Cipla toady said its US arm InvaGen Pharmaceuticals Inc has received final approval from the American health regulator to market generic Bupropion Hydrochloride extended release tablets used for treatment of major depressive disorder. "InvaGen Pharmaceuticals Inc has received final approval for its abbreviated new drug application (ANDA) for…

news

Santhera receives FDA grant in support of its ongoing phase I trial with Omigapil in congenital muscular dystrophy. FDA granted award of $246,000 in support of ongoing phase I trial with Omigapil (Callisto).   Source : reuters.com

news

European Commission grants orphan drug designation to ALXN1007 for the treatment of patients with graft-versus-host disease (GVHD). ALXN1007 is currently being evaluated in a phase 2 study in patients with newly diagnosed acute GI-GVHD.   Source : reuters.com

news

Lepu Medical Technology Beijing Co Ltd Says its unit Lepu Pharmaceuticals, Inc to invest 150 million yuan in a Beijing-based pharmaceutical company and plans to hold 75 percent stake in it via stake acquisition and capital injection. Says Lepu Pharmaceuticals, Inc to invest 90 million yuan in a Xinxiang-based pharmaceutical…

news

Mylan NV said it would launch the first generic version of its allergy auto-injector EpiPen for $300, half the price of the branded product, the drugmaker's second step in less than a week to counter the backlash over the product's steep price. The company reduced the out-of-pocket costs of EpiPen…

news

Hunan Hansen Pharmaceutical Co., Ltd. Says its wholly owned health industry subsidiary canceled cooperation with maternal and child care service center. Says the reason is that the cooperation project, including partnership enterprise establishment plan, didn't get approval from the government. Says previous plan disclosed on Sep. 8, 2015.   Source…

news

Nichi-Iko Pharmaceutical Co Ltd Says it completed full acquisition of Sagent Pharmaceuticals, Inc. via takeover bid, effective Aug. 29(the U.S. time).   Source : reuters.com

news

Drug firm Claris Lifesciences has received approval from the US health regulator for generic Flumazenil injection used for reversal of the sedative effects of benzodiazepines in the America market. The company has received abbreviated new drug approval from the United States Food and Drug Administration (USFDA) for Flumazenil injection USP…